David M. Kotick

2021 Inductees

David Kotick

David M. Kotick

Senior Science Technical Manager
Live, Virtual, and Constructive (LVC) simulation and training
Naval Air Warfare Center Training Systems Division
Graduate, University of Central Florida

5 U.S. Patents

David M. Kotick is the Senior Scientific Technical Manager for Live Virtual Constructive at the Naval Air Warfare Center Training Systems Division. A Florida native and double graduate of the University of Central Florida, Kotick the is one of the U.S. Department of Defense’s leading subject matter experts in the field of virtual communications.

With over 40 years of experience in the Navy Modeling and Simulation (M&S) Research and Development arena, Kotick has been at the forefront of designing and developing digital voice solutions to enable military forces to train as they would fight. Kotick holds multiple patents in the fields of digital communications and simulation technology. Among his many innovations, Kotick’s work on the family of systems comprising the Digital Radio Management System (DRMS) is foundational to Live-Virtual-Constructive (LVC) advancement, as it provides a single synthetic training communications system that enables realistic tactical communications across all warfare areas, classification levels, and releasable domains. Kotick further developed this technology to create the Virtual Tactical Bridge Embarked Synthetic Radio (VTBeSR), which enables voice and M&S data transport between a virtual training battle space and the live battle group, and supports live aircraft while underway and over the horizon. These innovations in digital communications and LVC have directly benefited the U.S. military’s readiness.

Kotick has been recognized with the 2016 Assistant Secretary of the Navy Dr. Delores M. Etter Top Scientist Award; Department of the Navy Meritorious Civilian Service Medal; the 2016 Commanders Excellence in Marine Air Ground Task Force Engineering Award for LVC Integration; and in 2017 was inducted into the National Center for Simulation’s Modeling and Simulation Hall of Fame. In 2013, he was named a NAVAIRSYSCOM Esteemed Fellow.

Susann Keohane

2021 Inductees

Susann Keohane

Susann Keohane

Global Research Leader for the Aging Initiative
Watson Health & Healthy Aging Innovation Leader
Master Inventor
IBM
Graduate, University of Florida

137 U.S. Patents

Susann Keohane is the IBM Watson Health Innovation Leader for Healthy Aging and Longevity and Emerging AI Product. Born in Fort Myers, she received her undergraduate degree from the University of Florida and has since become an expert in enabling human ability through emerging technologies with a strategic focus on accessibility research, aging-in-place Internet of Things (IoT) technology, and cognitive systems to deliver personalized insights and adaptive interfaces.

In her current role at IBM, she leads the Go-To-Market strategy and launch of new AI product, leveraging her AI/ML and IoT technical knowledge and experience in health research for the global aging population. Previously she headed a worldwide community of researchers, technologists, and academics who help governments, industries, and companies as they seek to develop solutions and technology-enabled services for consumers in the new ‘longevity economy.’ Harnessing her research on Artificial Intelligence (AI) for Healthy Aging and IoT Sensor Systems for Eldercare, Keohane also applies advanced analytics and Machine Learning (ML) techniques to model personal activities of daily living and generate new insights that reduce risk, reduce cost of care, and significantly improve quality of life for the elderly.

Keohane has been instrumental in rallying the world-wide teams, building strong partnerships with anchor clients, and establishing the IBM UCSD Center for Healthy Aging. She founded the IBM Aging-in-Place Research Lab which is designed to demonstrate IBM’s IoT-based AI solutions to support aging and create an environment to co-develop solutions with clients. She also served as a principal investigator for IBM’s collaboration with Rice University on cognitive sensor systems which led to the development of the IBM Multi-purpose Eldercare Robot Assistant (IBM MERA), a first-of-a-kind Watson-enabled robot prototype designed to assist the elderly and their caregivers.

She is an international speaker who has presented at the BBC World Changing Ideas Summit, MIT Future Innovators Forum, IBM World of Watson, and SXSW Interactive. She is an IBM Master Inventor and a member of the prestigious IBM Academy of Technology.

Dean Kamen

2021 Inductees

Dean Kamen

Dean Kamen

President
DEKA Research and Development
Founder
FIRST (For Inspiration and Recognition of Science and Technology)

440+ U.S. Patents

Dean Kamen is the President of DEKA Research and Development and part-time Florida resident. Internationally recognized as a disruptive innovator, entrepreneur, and a tireless advocate for science and technology, he is the inventor of such influential technologies as the Segway® and AutoSyringe™.

Kamen founded DEKA Research and Development Corporation in 1982 as a way to bring to market internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA’s development of the HomeChoice™ peritoneal dialysis system for Baxter International Inc., which allows patients to be dialyzed at home. Kamen also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Other Kamen-led DEKA teams have developed critical components of the UVAR™ XTS™ System, an extracorporeal photophereisis device marketed by Therakos, for the treatment of T-Cell lymphoma. Other notable developments include the Hydroflex™ surgical irrigation pump for C.R. Bard, the iBOT™ mobility device, an advanced prosthetic arm developed for DARPA known as the LUKE arm, and many more.

Prior to DEKA, Kamen was the founder of AutoSyringe, Inc., a medical device company that he built around his first breakthrough innovation—the novel portable drug infusion pump, AutoSyringe™. At age 30, Kamen sold AutoSyringe, Inc. to Baxter Healthcare Corporation.

Kamen also is the Founder of FIRST (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, FIRST has supported more than one million young people, ages 6 to 18, in more than 113 countries around the globe, and 10,000 students in Florida through notable programs like AMRoC Fab Lab in Tampa, the ROBOTICON FIRST Showcase held in Tampa each fall at the University of South Florida, and the Orlando Regional, one of the nation’s oldest FIRST Robotics Competition held each spring at the University of Central Florida in Orlando.

Kamen was awarded the National Medal of Technology in 2000 by President Clinton. He was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and he was inducted into the National Inventors Hall of Fame in 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations.

Roberta D. Goode

2021 Inductees

Roberta Goode

Roberta D. Goode

Founder and President
Altrec, LLC
Graduate, University of Miami

4 Patents

Roberta D. Goode is the founder and President of Altrec, LLC in Coral Springs, Florida—a consultancy firm with the mission of sharing knowledge and improving patient outcomes through a unique collaboration with the US Food and Drug Administration to train the next generation of regulatory engineers. She holds adjunct faculty appointments at the University of Miami College of Engineering and George Washington University School of Medicine and Health Sciences. A Florida native, Goode is a double graduate of the University of Miami, and her background spans both industry and academia, with broad experience in all aspects of medical device design, manufacturing and quality.

A highly successful entrepreneur, inventor, and biomedical engineer, Goode’s medical device inventions have transformed minimally invasive cardiac surgical and diagnostic procedures around the world. She discovered a novel application for elastomeric material, resulting in her four U.S. patents. Her pioneering designs focused on sheath introducers—the catheter surgeons use as a “tunnel” through which they can access cardiac systems to repair valves or insert stents or catheters, etc. Prior to Goode’s inventions, these procedures held a high degree of risk. Goode’s novel designs for sheath introducers significantly advanced cardiac surgery and diagnostics, in a minimally invasive manner, while also protecting the health of the patient by reducing blood loss. Her design was incorporated into the Cordis AVANTI Sheath Introducer, which continues to be sold today. More than 1 million catheterizations per day are performed in the U.S.

Goode has been recognized by the University of Miami with the Ozcan Ozdamar Biomedical Engineering Distinguished Alumni Award, and the Toppel Award for Excellence in Career Education. She was also named winner of President G.W. Bush’s High Growth Job Training Initiative, biotechnology curriculum contract.

Mark E. Dean

2021 Inductees

Mark Dean

Mark E. Dean, Ph.D.

Professor Emeritus
Tickle College of Engineering
University of Tennessee
Former Chief Technology Officer of the Middle East and Africa, and Fellow
IBM
Graduate, Florida Atlantic University

43 U.S. Patents

Mark E. Dean is Professor Emeritus and former Interim Dean of the Tickle College of Engineering and John Fisher Distinguished Professor at the University of Tennessee. Former Chief Technology Officer of the Middle East and Africa for IBM, IBM Fellow and a graduate of Florida Atlantic University, Dean’s research focuses on advanced computer architecture, data centric computing and computational sciences.

Dean has been the driving force behind a number of revolutionary computer system advances, from embedded systems to supercomputers, including testing of the first gigahertz CMOS microprocessor, and establishing the team that developed the Blue Gene supercomputer. He was also chief engineer for the development of the IBM PC/AT, PS/2 Model 70 & 80, the Color Graphics Adapter in the original IBM PC, and holds three of the nine patents for the original IBM PC. Most notably, he is named as the co-inventor of the Industry Standard Architecture (ISA) “bus,” which permitted add-on devices like the keyboard, disk drives and printers to be connected to the motherboard.

Over the course of his nearly 40-year career at IBM, Dean was responsible for technical strategy, technical skills development and exploring new technology-based solutions for the region. These responsibilities included the development of solutions specific for the emerging needs of the businesses in industry segments such as mobile services (banking, healthcare, education, government), natural resource management (oil, gas, mining, forest, water), cloud-based business services, and security (fraud protection, risk management, privacy, cybersecurity).

Dean’s most recent awards include: National Institute of Science Outstanding Scientist Award, member of the American Academy of Arts and Sciences, member of the National Academy of Engineering, IEEE Fellow, Black Engineer of the Year, the University of Tennessee COE Dougherty Award, member of the National Inventors Hall of Fame, and recipient of the Ronald H. Brown American Innovators Award.

Norma A. Alcantar

2021 Inductees

Norma Alcantar

Norma A. Alcantar, Ph.D.

Professor of Chemical, Biomedical & Materials Engineering
College of Engineering
University of South Florida

23 U.S. Patents

Norma A. Alcantar is a Professor of Chemical, Biomedical & Materials Engineering at the University of South Florida. Internationally known for her breakthroughs using plant-based technology to decontaminate water, Alcantar’s applications are imperative to future global sustainability and advances in biomedical applications for Alzheimer’s and cancer.

Over the course of the last 20 years, Alcantar has harnessed her research to invent new technologies using biomaterials derived from cactus plants that can expand the molecular removal of heavy metals, bacteria, sediments, radioactive isotopes, volatile organic compounds, and hazardous concentrations of fluoride and ammonia from water and soil. She has successfully demonstrated its use in many applications around the world, including Mexico, Bangladesh and notably in Port-au-Prince, Haiti after the 2010 earthquake. She has further applied this technology for sustainable soil systems that renew ground nutrients and enhance crop production. Alcantar has also developed a series of patents pertaining to improving capabilities of fish farming by enabling faster and more efficient removal of the bacteria that forms in the water tanks, and greatly reducing the amount of water and time previously required for mitigation. All of these innovations are playing a critical role in the global food-water-energy nexus.

Alcantar’s recent patents are biomedical applications of her technology for novel therapies to fight a number of disease processes. She designed new methods to treat amyloid diseases such as Alzheimer’s, by disrupting the formation of the plaques that can cause damage to brain tissue and function, and she developed a transformative drug delivery system to enhance treatment of brain and ovarian cancers.

Alcantar is a Fellow of the American Institute for Medical and Biological Engineering, and an NAI Senior Member. She has received a Fulbright U.S. Scholar Award, Jewish National Fund Fellowship, Excellence in Innovation Award, and USF NAI Chapter Outstanding Faculty Award.

Christopher Batich

2020 Inductees

Christopher Batich

Christopher Batich, Ph.D.

Professor
Biomedical Engineering
University of Florida

56 U.S. Patents

Christopher Batich is a professor at the University of Florida (UF) and inventor of Bioguard®, a groundbreaking anti-bacterial surface treatment material that is being used as the standard of care for advanced wound dressing and bacterial barrier in burn units and nursing homes throughout the United States. During his career at UF’s Department of Materials Science and Engineering, from 1997 until 2002, he was the founding director of the Graduate Biomedical Engineering (BME) Program and, from 2008 until 2010, the founding associate director and chief operating officer of the Clinical and Translational Science Institute (CTSI). The major focus for both groups was to leverage the science and engineering at UF to carry out research leading to improved patient care by healthcare professionals. As a result, Batich has been involved in research related to the creation of new drugs and biomedical devices in numerous collaborative projects with the Jacksonville UF Health Center. He worked with surface modification and analysis of polymeric materials as well as drug delivery for neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s. He also expanded on drug delivery methods to create devices to protect against disease carrying mosquitoes in conjunction with the UF Entomology Department and the local United States Department of Agriculture (USDA). More recently he collaborated with the Cardiology Department at the Jacksonville UF Health Center to develop a device being tested with Johns Hopkins to prevent some of the possible complications associated with cardiac ablation. Batich is a fellow of the AIMBE and holds 56 U.S. patents.

A MENTION ABOUT INVENTION
3 Questions for the Inventor

Q   Of your patents/inventions, which one is your favorite and why?

Bioguard is my favorite since it led to a truly new kind of antimicrobial surface as well as brought me into contact with a very collegial group of people that have been a pleasure to work with. The FDA had a meeting about advanced wound dressings in 2016 and every one of the several hundred products on the market released something into the wound. Several of the agents released had a negative effect on wound healing, and Bioguard was the only one which killed bacteria on contact without releasing anything. Some earlier technologies could also do that, but they were inactivated by proteins released in a wound. We found that Bioguard did not have that limitation. I learned a lot about regulations with this also since the FDA had stricter requirements for really new devices (de novo clearance) instead of devices similar to a device already on the market (the 510(k) process).

Q   What inspired you to become an inventor/innovator?

Every time one walks through a hospital or attends a seminar at a health center, that person can see the technology needs. The field of health care is very complex and full of problems that are amenable to engineering solutions if you can find a health care professional who can work with you on understanding the problem and finding ways to evaluate possible solutions. UF is rich in such professionals, and not just in the hospital. The UF entomology program is ranked number one in the world and joint projects have led to interactions with a wonderful group of people. They also work closely with the US Department of Agriculture in Gainesville on joint projects and again have people who are a real pleasure to work with.

Q   Do you have a personal process that you follow when inventing?

The first exposure to a problem which looks interesting and promising to investigate usually occurs by attending a seminar, reading, conversation or via an email from someone. The major next step is to find a collaborator who is expert in the area and has the time, interest, and collegiality to work with me. Some clinicians just do not have the time to communicate regularly on progress or express little interest. After some reading and learning, I try to find a student who would like to work on the project in a consistent way. The student provides regular communication, and they go into the lab to carry out the work. We then investigate the likely patent situation since results are more likely to be further developed if there is a possible profit eventually. I also try to work on some very promising projects that would not involve patents but finding interest and funding for them is much more difficult.

Nicholas Bodor

2020 Inductees

Nicholas Bodor

Nicholas Bodor, Ph.D.

Founder and CEO
Bodor Laboratories
Graduate Research Professor Emeritus
University of Florida

170+ U.S. Patents

Nicholas Bodor is founder and CEO of Bodor Laboratories in Miami, Florida and Graduate Research Professor Emeritus (active) at the University of Florida (UF), College of Pharmacy who is recognized internationally as a leader in drug discovery, design, and delivery. Bodor invented revolutionary retrometabolic drug design concepts that have improved the ratio of therapeutic effect and safety of medication. These concepts strategically combine chemical and enzymatic (metabolic) processes to achieve drug targeting, thereby producing safer drugs and safer environmental chemicals. The two major classes of retrometabolic drug design concepts contain chemical drug targeting systems (CDS) and the soft drugs (SD). The design concepts incorporated in the soft drug approaches were used by Bodor to develop a general and comprehensive program, including a computerized expert system, which can identify potential and possible metabolites and the corresponding safe active soft drugs or chemical delivery systems. A soft steroid, Loteprednol Etabonate, created by Bodor to treat ophthalmic infection and allergies is on the market in the U.S. and other countries. During his tenure at UF, he served as chair of the Medicinal Chemistry Department and was promoted to Graduate Research Professor in 1983. He later became the Executive Director of the college’s Center for Drug Discovery, founded by him in 1986. Bodor supervised the training of more than 50 doctoral students and 100 postdoctoral level research associates and fellows at UF before taking a leave of absence to accept a position at IVAX Pharmaceuticals in Miami. He is an AAAS Fellow and a named inventor on over 170 U.S. patents.

A MENTION ABOUT INVENTION
3 Questions for the Inventor

Q   Of your patents/inventions, which one is your favorite and why?

Interesting questions, not easy to answer. But here it is:

N.Bodor “Soft Steroids Having Antiinflammatory Activity” U.S. Pat. 4,996,335, February 26,1991. It is my first favorite, simply, because it covers my first drug that got to the market (in 1998). The active compound, named Loteprednol Etabonate, is now the active component of some eight or nine drug products, marketed by different companies. It is a very successful drug, as indicated by an article published by T.L. Comstock and J.D. Sheppard “Loteprednol Etabonate for inflammatory conditions of the anterior segment of the eye: twenty year of clinical experience with a retrometabolically designed corticosteroid” Expert Opinion on Pharmacotherapy, 2018, 19:4, 337-353. Another favorite is: N.Bodor “Brain Specific Drug Delivery” U.S. Pat. 4,479,932; October 30, 1984, since this a very general patent describing a very novel and general chemical-enzymatic way to specifically target drugs to the brain. When we filed it, it was more than 450 pages long, and we have a large number of follow up patents.

Q   What inspired you to become an inventor/innovator?

I am a scientist, driven by interest to find novel stuff. Many of these findings I published in some 500+ research articles. However, some of the useful new ideas can only be developed, if protected by intellectual property, that is patents. Patenting is a very different field than publications, but they are critical in drug discovery.

Q   Do you have a personal process that you follow when inventing?

This is a very complex question. I feel that I work constantly, some ideas and questions are always in the back of my mind. Solutions come unexpectedly and sometimes unrelated to the very scientific fields, reading a novel, practicing sport, watching a show, etc. could trigger the answers. Most solutions are not simply logical. The other important aspect is to work simultaneously on a number of different projects, something will always work, thus the interest and progress can be maintained.

Harvey Firestone

2020 Inductees

Harvey Firestone

Harvey Firestone

Founder
Firestone Tire and Rubber Company

1868–1938

4 U.S. Patents

Harvey Firestone, innovative businessman and founder of Firestone Tire and Rubber Company was a pioneer in the rubber industry who did much to advance scientific research in Florida. He acted as a tireless booster for the state, purchasing a winter estate on the east coast where he hosted companywide retreats and promoted the area to all who visited. Most notably, Firestone collaborated with Thomas Edison and Henry Ford as co-founder of the Edison Botanic Research Corporation. Together, their groundbreaking search for a domestic source of natural rubber led to botanical and chemical advancements, helping to pass the Plant Patent Act of 1930 through Congress. Firestone’s contributions to this endeavor were critical as he utilized his international business and political connections to advance the project while contributing crucial scientific knowledge regarding the chemistry of rubber. Today, the Edison Botanic Research Corporation Laboratory, located at the Edison and Ford Winter Estates in Fort Myers, has been designated a National Historic Chemical Landmark. Firestone also utilized his substantial political clout to encourage the passage of bills which furthered rubber research in Florida, benefiting sites like Chapman Field in Coral Gables. Firestone tires later became synonymous with automotive racing, which took root in Florida beginning in the 1930s, earning the area national renown. Firestone’s contributions to the automotive industry are plentiful and his impact on the state of Florida may be equally important. Today, his legacy lives on as his former east coast home is now the site of the celebrated Fontainebleau Hotel in Miami. In 2006 he was elected into the National Inventors Hall of Fame. He holds 4 U.S. patents.

A Mention about Invention

Harvey Firestone was born on December 20, 1868 in Columbiana, Ohio, the second of three children (all sons) of Benjamin and Catherine Firestone. He grew up there on the family farm, attending school in a one-room schoolhouse, graduating from high school, and completing a business-college course in Cleveland. He worked two years as a bookkeeper for his uncle, head of the Columbus Buggy Company; by 1892, he was in charge of the entire Michigan district. In November 1895, he married Isabelle Smith of Jackson, Michigan.

When his uncle’s company went into receivership, Harvey drove a buggy with rubber-tired wheels for the receiver. An idea came to him, as he later put it: “My future was right on the wheels of my buggy.” He and an acquaintance established a company in Chicago in 1896; after three years it was sold to a competitor, with Firestone receiving $41,666.67 in cash. He relocated to Akron, Ohio, where the big tire-making companies were located. On August 3, 1900, he organized the Firestone Tire and Rubber Company; by putting in his own patent and money, he acquired half the shares of the $50,000 corporation. After 1903, when it began to manufacture its own products, the company prospered.

The beginning of a long and important business relationship, which also led to a personal friendship, occurred in 1906 when Henry Ford placed a large order with him. Firestone, Ford, and Thomas Edison later joined in summer camping trips (1915-24) that won national attention.

In 1907, he offered a “dismountable rim” which permitted a spare to be substituted. His tires became popular because of their use by automobile race winners. By 1913, the company’s annual sales were $15,000,000. Firestone, Goodyear, Goodrich, United States Rubber, and Fisk were the “big five.”

The 1920-21 depression left the company with a $43,000,000 debt. Firestone immediately cut prices, increased sales, and paid off the debt by 1924. He also cut wages and was able to forestall organized labor until the mid 1930s. In 1923, Firestone introduced the balloon tire, soon to become standard for most types of motor vehicles. Firestone made it through the 1929 depression without suspending dividend payments and continuing his position in the trade.

In 1932, Henry Ford’s V-8 engine meant Firestone had to develop a new tire; then he demanded it be at the same price Ford was initially paying. His Ground Grip tire, put out in 1935, used a new tread design that became widely successful.

In 1937, his company was showing profits of $9,000,000 — and was supplying approximately one-fourth of all the tires in the United States. The company had expanded its manufacturing facilities and had 12 additional U.S. and eight overseas factories devoted to steel, rubber, and textile products.

Firestone used “consensus management” by getting opinions of his management staff and having them come to obvious decisions. He also avoided bureaucratic hierarchy. His forty managers sent monthly reports to him. He also had a genius in choosing the right person for the right job. “My most valuable executives have picked themselves by their records. People prove themselves at lower levels.”

Real keys to his leadership were his ability to delegate responsibility — and to know men. At the Firestone Company, there was a tremendous commitment to getting the job done. He was one of the first in the country to offer company stock to his employees at reduced rates, so that they could be part of the operation. He was sad to see unions come in because he lost personal contact.

Credit: Edison and Ford Winter Estates

Les Kramer

2020 Inductees

Les Kramer

Les Kramer, Ph.D.

Vice President of Engineering and Manufacturing
TaiLor Made Prosthetics

17 U.S. Patents

Les Kramer is the Vice President of Engineering and Manufacturing at TaiLor Made Prosthetics, LLC in Orlando, and a board member of the University of Central Florida’s College of Sciences and Nanoscience Center who created a remarkably advanced carbon fiber composite prosthetic foot that has improved the lives of many amputees. Accepting a job at Lockheed Martin, Kramer moved to central Florida in 1985, where he started changing the technology of composite materials by improving properties and producing carbon nanotube structures to encourage morphing and multifunctional material behaviors. Later, he produced light weight carbon nanotube/foam core composites with outstanding structural performance that were held together by advanced adhesives. Kramer’s research in adhesives technology transferred into Steam Turbine blade repair and later technology licensed for upgrading Florida phosphate pump repairs. Additionally, maintenance of his composite materials, which contain embedded sensor suites led to many of Kramer’s inventions becoming key technologies for improvised explosive device (IED) detection as well as remote sensing for the military. In 2010, he retired from Lockheed Martin and co-founded TaiLor Made Prosthetics to focus on providing amputees with improved foot prosthesis performance and comfort. His prosthetic foot design returns energy sequentially to the wearer’s heel and toe, has 100% replacement of components, and is totally customizable. Hundreds of people including Boston Bombing victims and Wounded Warrior® amputees, have confirmed its unique performance that allows walking backwards as well as smooth action on stairs and ramps. Kramer is a named inventor on 17 U.S. patents.

A MENTION ABOUT INVENTION
3 Questions for the Inventor

Q   Of your patents/inventions, which one is your favorite and why?

Actually, I have two favorite inventions for two different reasons.

There is no doubt in my mind that the comfort and control benefits received by lower limb amputees when using the TaiLor Made Prosthetic Foot™ have been a life-changing experience for these people. To date, we have approximately 2,000 amputees using my invention including two Boston Marathon bombing victims. Because of its unique modular design, the foot can be reconfigured to meet the specific needs of the owner from normal walking and running during daily life to athletic pursuits from golf to playing soccer, rock climbing, and competitive skateboarding. This prosthetic foot has an energy return system that helps the amputee obtain a near perfect walking gait while not having to drag their foot vertically when walking up stairs or losing control when negotiating ramps. When I meet the amputees that wear my prosthetic foot, it is not unusual that I get thanks and hugs for increasing their freedom of mobility.

My second favorite invention is ABEST™ (Adhesive Bonding Erosion Shield Technology) and was a process I developed to simultaneously cure an adhesive and a seal surrounding the adhesive in order to provide an environmentally impervious adhesive joint. The initial application for this technology was to avoid welding or brazing of steam turbine erosion shields that were difficult processes as field repairs and could potentially damage already installed turbine blades. The low-cost, speed of installation, and low risk of damage were all significant commercial advantages to electric power companies in order to shorten turbine outages. This entire process was developed in my garage in Longwood, Florida and was tested at a power plant in Huntley, New Zealand. This invention taught me many important lessons about becoming an entrepreneur. But the most important lesson was not to give up on a good idea because initial trials fail. You see, after two field trials in New Zealand, my idea for steam turbine erosion Shield applications did not work after an extended period of time. Fortunately, I met the President of the Florida Phosphate Council during a chance encounter at the University of Florida and learned that phosphate rock impact damage was a big problem for the pumps that provide the feedstock to Florida fertilizer factories. After several discussions with a major phosphate pump manufacturer, I found that my adhesive bonding erosion shield technology would work perfectly in this device. For several years, I ran a small business repairing phosphate mining pump components with the ABEST™ patented technology. As a side benefit of this work, I was able to take a wonderful extended vacation in the beautiful country of New Zealand and develop a long-term friendship with my customer.

Q   What inspired you to become an inventor/innovator?

I grew up on the south side of Chicago. During World War II, my Dad had two years of engineering courses at Armor Institute of Technology (i.e., now IIT) before the program was terminated at war’s end. He returned to the family paint store for the rest of his career. Fortunately for me, he had learned basic engineering skills in college and hands-on skills (i.e., lab skills) at the paint store that he taught me. He was a wonderfully skilled HO gauge train model maker and taught me how to use hand tools at an early age. By age 8, I had won my first award from the local hobby shop for a “stick and tissue” built model airplane. When I wanted to enter a 1 tube regenerative radio receiver in my school science fair, he taught me how to solder and fabricate sheet metal. When I wanted to build a “Giant Repulsion Coil” that would levitate an aluminum ring due to induced eddy currents, he located and bought me the double cotton covered No. 12 copper wire and transformer laminations. Unfortunately, we destroyed my mother’s dining room table pad in the act of winding the coil, but the device worked beautifully and was exhibited at the Chicago Science Fair. My Dad gave me the skillset and mental tools required to develop an inventor’s mindset.

While I could do some chemical experimenting in my Chicago apartment such as using lemon juice as “Invisible Ink” and exploring high speed photography in our apartment “Darkroom”, I really needed a collaborator with “lab space” (i.e., a basement with a workbench and tools). Fortunately, I had a friend, Sy, who lived in a house next to my apartment building and had similar interests. Together, we built some Heathkit electronics and other devices. One day, we decided to build a robot from an old garbage can mounted to downspout legs. The legs were mounted to a base containing the drive wheels. The wheels were belt driven directly by a large AC electric motor mounted in the garbage can. The initial “prototype” had no provision for speed control (it was on or off) or steering. Just as we plugged the robot’s motor into the electrical socket, Sy’s mother came down the basement stairs with a plate of cookies. The robot wheels “peeled” tire tracks in the linoleum floor and aimed directly toward Sy’s mother – the cookies went flying!! Needless to say, no one was hurt, but my robot building ceased immediately. A year later, Sy and I constructed a device to make time lapsed movies of Morning Glories that were growing on his garage. For one month during the summer, we hauled a war souvenir Nazi electric movie camera, a large Lionel train transformer, and a crude but effective timing device to activate the camera onto the garage roof. The resulting color movies of morning glories opening and closing each day were unbelievably detailed considering the home-made nature of the equipment. So, invention inspiration also requires the ability to conduct experiments. The presence of a willing colleague and a large working space is a good adjunct as well!!

Q   Do you have a personal process for inventing?

Obviously, you need to identify an intriguing problem that needs to be solved by an invention as a first step!!  When I first recognize the need for the invention, I may have some initial potential solutions “pop into my mind”, but I never initially act on these ideas at first. Rather, I “sleep on it” and find that my mind subconsciously works to resolve my important vexing technical problems. Sometimes, a particularly difficult problem requires many nights of thought, but often in the morning, I wake up with a clearer understanding of the problem solution. During my patent productive years at Lockheed Martin, I used to say that I thought up most of my patentable ideas while shaving!! 

A few of my patents are “Gedanken Experiments” (Thought Experiments) that have proven to work in my mind but are unproven by experiment. One of my foot patents is an example of this approach where the patent describes a Bluetooth enabled microprocessor prosthetic foot that has not been reduced to practice, but I know must work because of the underlying maturity of the components and of the software.  Evidently USPTO agreed!!

No matter how a patentable idea is conceived, there needs to be supporting testing, standards compliance, manufacturing considerations, quality control methods, and a host of other requirements to prove that the invention is worthy of commercialization investment and efforts.